
Privacy notice | Accessibility statement | Terms and conditions | Login | Contact |
UK data driving real-world evidence
Bibliography
Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 5 February 2021) and papers are listed below and in the PDF below.
If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.
Download:
(PDF, 3MB, 220 pages)This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website.
“Association between NICE guidance on biologic therapies with rates of hip and knee replacement among rheumatoid arthritis patients in England and Wales: An interrupted time-series analysis”, Semin Arthritis Rheum, vol. 47, pp. 605-610, 2018.
, “Can the publication of guidelines change the management of early rheumatoid arthritis? An interrupted time series analysis from the United Kingdom”, Rheumatology (Oxford), vol. 54, pp. 2244-8, 2015.
, “The changing use of disease-modifying anti-rheumatic drugs in individuals with rheumatoid arthritis from the United Kingdom General Practice Research Database”, Rheumatology (Oxford), vol. 44, pp. 1394-8, 2005.
, “Descriptive epidemiology of hip and knee replacement in rheumatoid arthritis: an analysis of UK electronic medical records”, Semin Arthritis Rheum, 2019.
, “How accurate are diagnoses for rheumatoid arthritis and juvenile idiopathic arthritis in the general practice research database?”, Arthritis Rheum, vol. 59, pp. 1314-21, 2008.
, “The impact of bmi and smoking on risk of revision following knee and hip replacement surgery: evidence from routinely collected data”, Osteoarthritis Cartilage, 2019.
, “The importance of the disease process and disease-modifying antirheumatic drug treatment in the development of septic arthritis in patients with rheumatoid arthritis”, Arthritis Rheum, vol. 57, pp. 1151-7, 2007.
, “Mortality in Wegener's granulomatosis: a bimodal pattern”, Rheumatology (Oxford), vol. 50, pp. 697-702, 2011.
, “Protective effect of antirheumatic drugs on dementia in rheumatoid arthritis patients”, Alzheimers Dement (N Y), vol. 3, pp. 612-621, 2017.
, , ,